Bos indicus (zebu cattle): 109553316
Help
Entry
109553316 CDS
T04792
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
biu
Bos indicus (zebu cattle)
Pathway
biu01524
Platinum drug resistance
biu04010
MAPK signaling pathway
biu04115
p53 signaling pathway
biu04148
Efferocytosis
biu04210
Apoptosis
biu04215
Apoptosis - multiple species
biu04623
Cytosolic DNA-sensing pathway
biu04650
Natural killer cell mediated cytotoxicity
biu04657
IL-17 signaling pathway
biu04668
TNF signaling pathway
biu04726
Serotonergic synapse
biu04932
Non-alcoholic fatty liver disease
biu04933
AGE-RAGE signaling pathway in diabetic complications
biu04936
Alcoholic liver disease
biu05010
Alzheimer disease
biu05012
Parkinson disease
biu05014
Amyotrophic lateral sclerosis
biu05016
Huntington disease
biu05020
Prion disease
biu05022
Pathways of neurodegeneration - multiple diseases
biu05132
Salmonella infection
biu05133
Pertussis
biu05134
Legionellosis
biu05145
Toxoplasmosis
biu05146
Amoebiasis
biu05152
Tuberculosis
biu05160
Hepatitis C
biu05161
Hepatitis B
biu05162
Measles
biu05163
Human cytomegalovirus infection
biu05164
Influenza A
biu05165
Human papillomavirus infection
biu05167
Kaposi sarcoma-associated herpesvirus infection
biu05168
Herpes simplex virus 1 infection
biu05169
Epstein-Barr virus infection
biu05170
Human immunodeficiency virus 1 infection
biu05200
Pathways in cancer
biu05203
Viral carcinogenesis
biu05205
Proteoglycans in cancer
biu05206
MicroRNAs in cancer
biu05210
Colorectal cancer
biu05222
Small cell lung cancer
biu05416
Viral myocarditis
biu05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
biu00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
109553316 (CASP3)
04668 TNF signaling pathway
109553316 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
109553316 (CASP3)
09143 Cell growth and death
04210 Apoptosis
109553316 (CASP3)
04215 Apoptosis - multiple species
109553316 (CASP3)
04115 p53 signaling pathway
109553316 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
109553316 (CASP3)
04650 Natural killer cell mediated cytotoxicity
109553316 (CASP3)
04657 IL-17 signaling pathway
109553316 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
109553316 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
109553316 (CASP3)
05206 MicroRNAs in cancer
109553316 (CASP3)
05205 Proteoglycans in cancer
109553316 (CASP3)
05203 Viral carcinogenesis
109553316 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
109553316 (CASP3)
05222 Small cell lung cancer
109553316 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
109553316 (CASP3)
05161 Hepatitis B
109553316 (CASP3)
05160 Hepatitis C
109553316 (CASP3)
05164 Influenza A
109553316 (CASP3)
05162 Measles
109553316 (CASP3)
05168 Herpes simplex virus 1 infection
109553316 (CASP3)
05163 Human cytomegalovirus infection
109553316 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
109553316 (CASP3)
05169 Epstein-Barr virus infection
109553316 (CASP3)
05165 Human papillomavirus infection
109553316 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
109553316 (CASP3)
05133 Pertussis
109553316 (CASP3)
05134 Legionellosis
109553316 (CASP3)
05152 Tuberculosis
109553316 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
109553316 (CASP3)
05145 Toxoplasmosis
109553316 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
109553316 (CASP3)
05012 Parkinson disease
109553316 (CASP3)
05014 Amyotrophic lateral sclerosis
109553316 (CASP3)
05016 Huntington disease
109553316 (CASP3)
05020 Prion disease
109553316 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
109553316 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
109553316 (CASP3)
05416 Viral myocarditis
109553316 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
109553316 (CASP3)
04932 Non-alcoholic fatty liver disease
109553316 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
109553316 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
109553316 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
biu01002
]
109553316 (CASP3)
Enzymes [BR:
biu01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
109553316 (CASP3)
Peptidases and inhibitors [BR:
biu01002
]
Cysteine peptidases
Family C14: caspase family
109553316 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
109553316
NCBI-ProteinID:
XP_019808854
UniProt:
A0A6P5BHH7
LinkDB
All DBs
Position
27:16446483..16471670
Genome browser
AA seq
271 aa
AA seq
DB search
MSMENTENSVDSKSIKTSETKILHGSKSMDSGISLEESYKMDYPEMGLCIIINNKNFHEN
TGMCRDSFHLRETFMNLKYEVRIKNDLTCKEMLELMSNVSKEDHSKRSSFICVLLSHGEE
GIIFGTNGPVNLKKLASFFRGDYCRSLTGKPKLFIIQACRGTELDCGIETDSGAEDDMAC
QKIPVEADFLYAYSTAPGYFSWRNAKNGSWFIQVLCEMLKKYAHRLELMHILTRVNRKVA
IEYESFSTDSAFHAKKQIPCIMSMLTKELYF
NT seq
816 nt
NT seq
+upstream
nt +downstream
nt
atgtccatggagaacactgaaaattcagtggattcaaaatccattaaaacttcagagaca
aagatcttacatggaagcaaatcaatggactctggaatatccttggaagagagttacaaa
atggattatcctgaaatgggtttatgtataataatcaataataagaacttccacgaaaat
actggtatgtgtcgtgacagttttcacctcagggaaacattcatgaacttgaaatacgaa
gtcaggattaaaaatgatcttacatgtaaagaaatgttggaattaatgagcaacgtttct
aaagaagaccatagcaaaaggagcagttttatttgtgtgcttctaagccatggtgaagaa
ggaatcatttttggaaccaayggacccgtcaatttgaaaaaattagcaagtttcttcaga
ggggactattgcagaagtctgactggaaaacccaaacttttcattattcaggcctgccga
ggcacagaactggactgtggtattgagacagacagtggtgctgaggatgacatggcctgt
cagaaaataccagttgaggcagacttcttgtacgcatattctacagcacctggttacttt
tcctggcgaaatgcaaagaacggatcctggttcatccaggttctttgtgagatgctgaaa
aagtacgctcacaggctcgagctcatgcacattcttactcgggttaaccgaaaggtagca
atagaatatgagtccttttctaccgattctgcttttcatgcaaagaaacagattccttgt
attatgtctatgctcacaaaagaactgtatttctaa
DBGET
integrated database retrieval system